WISAP grows with new shareholder from China
On behalf of WISAP’s then shareholder, Blue Cap AG, MRL Advisors acted as exclusive M&A advisor in the search for a new owner and initiated, structured and accompanied the entire transaction through to closing. WISAP is a successful medium-sized niche supplier of medical instruments and devices for minimally invasive surgery in the field of laparoscopic […]
MRL Advisors takes a stake in EMTS Group Pte. Ltd. in Singapore and Manila
By Frank-Christian Raffel EMTS – European Medtech Services – has set itself the goal of improving the availability of medical technology in Southeast Asia. MRL Advisors has joined as a founding partner. The former top manager of the Austrian Fresenius-VAMED, Matthias Köhler, had the idea to found the company when Southeast Asia was no longer […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]